Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. 1977

M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston

Subjects (109) with symptomatic Paget's disease of bone were treated with 5, 10, or 20 mg of sodium etidronate (EHDP)/kg body weight - day for 6 to 24 months. Significant decreases in serum alkaline phosphatase and urinary hydroxyproline were noted after 6 months of therapy; no significant further improvement resulted after prolonged therapy. Some patients maintained biochemical remission after withdrawal of EHDP but others showed a relapse, related primarily to the pretreatment severity. Clinical improvement was noted in 61% of the patients. Similar findings were seen after a second course of EHDP. No side-effects were noted in patients treated with 5 mg of EHDP/kg body weight - day. In patients treated with 10 or 20 mg of EHDP/kg body weight - day, severe diarrhea, bone pain, and nontraumatic fractures were noted in 3, 13, and 12 patients respectively. Quantitative histomorphometry showed mineralization delay in patients receiving 10 or 20 mg of EHDP/kg body weight - day but not in those receiving 5 mg/kg body weight - day. Five milligrams of EHDP/kg body weight - day was effective and appears to be safer than the higher doses.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010001 Osteitis Deformans A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry. Paget's Disease of Bone,Osseous Paget's Disease,Paget Disease of Bone,Paget Disease, Bone,Pagets Disease, Bone
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001857 Bone Matrix Extracellular substance of bone tissue consisting of COLLAGEN fibers, ground substance, and inorganic crystalline minerals and salts. Bone Matrices,Matrices, Bone,Matrix, Bone
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic

Related Publications

M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
October 1985, Irish medical journal,
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
August 2012, Morphologie : bulletin de l'Association des anatomistes,
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
January 1972, Seminars in drug treatment,
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
January 1977, Clinical orthopaedics and related research,
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
January 1977, Clinical orthopaedics and related research,
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
October 1991, Revista clinica espanola,
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
May 1982, Annals of internal medicine,
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
May 1999, The American journal of medicine,
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
June 1986, British medical journal (Clinical research ed.),
M R Khairi, and R D Altman, and G P DeRosa, and J Zimmermann, and R K Schenk, and C C Johnston
November 1985, The American journal of medicine,
Copied contents to your clipboard!